(Reuters) -British consumer healthcare company Haleon lowered its annual organic revenue growth forecast to 3.5% on Thursday, citing weaker performance in the United States.
The Sensodyne toothpaste-maker had previously expected organic revenue growth to be in a 4% to 6% range for the year.
“The consumer environment in North Americais likely to remain subdued,” CEO Brian McNamara said in a statement.
The company reported an organic revenue growth of 3% for the three months ended June 30, compared with 3.3% expected by analysts in a company-compiled poll.
Adjusted operating profit for the first half of 2025 came in at 1.24 billion pounds ($1.64 billion), compared with analysts’ expectations of 1.22 billion pounds, according to a company-compiled consensus.
($1 = 0.7541 pounds)
(Reporting by Unnamalai L and Raechel Thankam Job in Bengaluru; Editing by Mrigank Dhaniwala and Subhranshu Sahu)
